Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-06

Clinical Trial Update: Optimized Glycemic Control in Heart Failure Patients With DM2:"Effect on Left Ventricular Function and Skeletal Muscle" [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether optimized glycemic control improves left ventricular function and skeletal muscle in patients with Type 2 diabetes and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Aarhus | Conditions: Type 2 Diabetes, Heart Failure | Phase 2 | Status: COMPLETED